You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: April 1, 2020

DrugPatentWatch Database Preview

Litigation Details for ViiV Healthcare Company v. Gilead Sciences, Inc. (D. Del. 2018)

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in ViiV Healthcare Company v. Gilead Sciences, Inc.
The small molecule drugs covered by the patent cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for ViiV Healthcare Company v. Gilead Sciences, Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-02-05 174 Opinion - Memorandum Opinion infringing United States Patent Number 8,129,385 (the #385 patent). The #385 patent covers pharmaceutical…principle of patent law that the claims of a 2 patent define the…requirements for a patent.") ( citation omitted). It is the claims-not the patent's written description…Bictegravir infringes claims 2 and 6 of the #3 85 patent under the doctrine of equivalents. That doctrine… literally infringe upon the express terms of a patent claim may nonetheless be found to infringe if External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.